PLX Operating Cash Flow (Statement)

Protalix Biotherapeutics Inc · Operating Cash Flow (Statement)

PLX logo

PLX Operating Cash Flow (Statement)

Latest reported-$10.40M
PLX Quarterly Cash from Operations (-$70.00K → -$10.40M)
High-resolution chart · PNG

PLX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Protalix Biotherapeutics Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-10,400,000
22,025,000
2,030,000
-3,732,000
-5,233,000
-5,058,000
3,991,000
4,105,000
-3,610,000
4,188,000
3,595,000
-6,888,000
4,973,000
-2,998,000
-2,611,000
-9,204,000
-7,356,000
-5,829,000
-5,087,000
-1,880,000
6,516,000
-9,834,000
-7,550,000
-3,604,000
-7,835,000
-7,117,000
-3,687,000
-3,225,000
-5,170,000
-7,276,000
-4,004,000
13,639,000
-7,964,000
-9,413,000
17,590,000
-10,539,000
-8,619,000
-8,426,000
-7,338,000
-3,443,000
-11,692,000
-9,625,000
-3,857,000
-8,660,000
-5,346,000
-6,421,000
-4,874,000
-9,548,000
-6,519,000
-8,340,000
-4,742,000
-8,216,000
-8,109,000
-9,586,000
1,821,000
-8,029,000
13,124,000
-6,281,000
-6,612,000
-8,147,000
-4,823,000
-3,988,000
-8,031,000
-9,680,000
-11,808,000
-8,945,000
59,118,000
-5,411,000
-3,273,000
-5,982,000
-2,239,000
-6,329,000
-3,640,000
-3,807,000
-3,860,000
-1,673,000
-2,097,000
-2,819,000
-4,931,464
-99,169
-6,853
-53,514
-2,552
-21,364
-18,037
-30,522
-15,352
-43,078
-43,474
-66,221
-24,215
-20,528
-42,787
-49,152
-26,255
-22,727
-35,348
-62,256
-1,325,474
-33,578
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.